With technology reaching into nearly every aspect of human life, at a faster rate than ever, it’s inevitable that tech firms would turn their attention to health care. In an interview with CNBC, Yitzhak Peterburg, the president and CEO of Israel-based Teva Pharmaceuticals said that pharmaceutical firms should prepare for disruption, and potential competition, from tech firms.
According to Peterburg, who runs what is said to be the world’s largest producer of generic drugs, is not only looking at other pharmaceutical firms. He now sees tech companies like Amazon and Google as potential competitors. It’s well-known that tech companies are researching on how to enter the multi-billion dollar health care industry.
More venture capitalists are pouring money into health technology startups. These startups, in turn, are hiring more biomedical experts as advisors. Some of the more obvious health care areas that tech firms can enter involve the storage and distribution of patients’ medical history and related information. Reportedly, Apple is working to have patients’ medical information made available on iPhones.
Tech firms can go beyond medical data. Amazon, for example, might end up competing with pharmacies if it implements a plan to sell medications online. It would be no surprise if a tech firm offers, one day, a diagnostic test, or even a treatment that would be touted as better than what pharmaceutical and healthcare firms are selling.
In fact, one tech company has done exactly that, but with disastrous, cautionary results. Elizabeth Holmes, the founder of health technology start-up Theranos, was once ranked by Forbes as one of the richest self-made women, with a net worth of $4.1 billion. When the Theranos scandal unfolded, Forbes revised its ranking of Holmes, putting her net worth at zero.
Holmes had apparently modeled herself after Steve Jobs and promised to change health care with technology. She promised investors and the public that her device, called the Edison, was able to conduct a wide range of tests using only a pinprick of blood from a finger. Some experts doubted this, but Holmes pushed on.
Some criticized her for running Theranos like a tech firm instead of a medical or healthcare company. Like Steve Jobs, she demanded secrecy from employees and managers, and refused to listen to advisers who were actual scientists and medical experts. She refused to publish papers in peer reviewed medical journals and allow experts to assess if her diagnostic test really worked.
Later on, after investigations by the media, government regulators, and the FBI, there was a general consensus that the Edison did not work. It was also revealed that blood tests done at Theranos clinics were wildly inaccurate. This put patients’ health and lives in danger. Vanity Fair’s special report on the Theranos debacle is particularly interesting.
Theranos remains a cautionary tale with one glaring lesson: tech firms, if they get into health care and medicine, should concern themselves with more than just technology. They should make sure they get the medical science right, and be transparent about it.
Crowdfunding offers a way in raising capital without having loans
Magma Partners launches first Sino-Latin American accelerator venture
Canceling your travel insurance policy? Yes, it can be done
The benefits of supporting sustainable palm oil
Why is it becoming harder for millennials to be homeowners?
This fast-growing organic products stock already has space on Whole Foods’ shelves
The CBD industry is enjoying a boost from the lifestyle sector
Cannabis acceptance grows as hemp industry leader PotNetwork Holding breaks CBD sales records
Why Vapor Group Inc. might be the breakout penny stock you’ve been looking for in 2018
When you should consult your financial advisor
Promoting women’s football in Malta by UEFA projects
Euro NCAP marks its 20th anniversary with two crash tests
European Parliament’s International Trade Committee backs CETA
The American Heart Association has released four new PSAs
PwC presents 20th global CEO survey results in Switzerland
Featured5 days ago
When you should consult your financial advisor
Featured2 days ago
CBD stocks emerge strong in the growing cannabis industry, marijuana legalization
Crypto19 hours ago
One of America’s oldest gold mines enters the crypto-century
Featured18 hours ago
This hemp market player’s growth is about to go into overdrive
Entrepreneurship4 days ago
Woman to Watch: Hudson’s Bay CEO Helena Foulkes
Featured4 days ago
5 ways investing in STEM programs could benefit city education
Commodities4 days ago
Cellulosic ethanol production needs to step up to meet expectations
Business3 days ago
Disney announces price hikes for Disneyland tickets in the US